The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
about
Repurposing metformin for cancer treatment: current clinical studiesIs diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studiesThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsAdherence to oral diabetes medications and glycemic control during and following breast cancer treatment.Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskMetformin as an adjuvant treatment for cancer: a systematic review and meta-analysisUpdate on immune checkpoint inhibitors in gynecological cancersLung Cancer Mortality Trends in China from 1988 to 2013: New Challenges and Opportunities for the Government.Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studiesDiabetic oncopathy--one more yet another deadly diabetic complication!Association between diabetes, diabetes treatment and risk of developing endometrial cancer.Association of type 2 diabetes genetic variants with breast cancer survival among Chinese womenSurvival of patients with stage IV lung cancer with diabetes treated with metformin.Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.Effect of metformin on apoptosis induction in ovarian cancer cells.Clinical benefits of metformin in gynecologic oncology.Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning.Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancerMetformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score AnalysisRepurposing metformin for the prevention of cancer and cancer recurrence.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal CancerIncreased 30-day mortality in patients with diabetes undergoing surgery for colorectal cancer.Recent advances in the use of metformin: can treating diabetes prevent breast cancer?Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.One author replies.Effect of metformin on the incidence of head and neck cancer in diabetics.Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis.SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
P2860
Q26752651-A1017AE0-FDDB-4AAD-AEDE-32D2ABB1F8D1Q27011756-BBCC15C8-50C3-47A5-841C-8788EAD1BE82Q27026813-9CBB24F9-F263-468F-ABF9-88DDD68BCFB8Q27331637-A131794B-E032-43AB-AAC7-0F0899472B64Q28072521-6273DA6B-5952-4109-848F-77F18E78997EQ28074225-9993DF76-E1FB-44C0-B4FD-FD22BCD4A083Q28076497-4C0762AB-B65B-4313-A6F1-2B68B75BB0C4Q30380099-51C075E1-CD77-4696-BFA7-32C4C5EEE4BBQ33672932-BFB81FCC-8B32-4417-A47F-7B333FACB068Q33688699-FE0D4171-2EE3-4B46-9087-6B83D0D9C67FQ34272097-B414BCCF-9A69-43EB-B896-90C4D5044AB3Q34283665-3FE8329F-9C6F-42D5-841E-8A192784CE5AQ35094977-8408BA18-2DA2-472B-8063-3F27DA83CB4EQ35153493-BBEF03E3-1189-4F47-B176-24CCB5277890Q35176774-DAF7DAE8-635B-4E95-9F60-23D8706678DDQ35558619-E3728245-9A0A-4128-8FE9-72D6C1A033F3Q35761271-8CC8D942-351C-4464-90EB-F9D29BD9C07BQ35871269-EB5DDAE1-A59E-4C43-AE7E-C665D597C2D1Q36103093-8AF605EF-1100-43F1-8A6F-04B7DF974622Q36182935-B0245928-2F25-4564-952F-60704F0C1E1DQ36478779-845B3D79-0C48-4410-A55C-B368CBD1622DQ36524748-E5399F42-7B5F-41F7-B60F-F6B8BC9FF1ECQ36772943-F154F289-976D-49A3-A613-D954FDFA187FQ37137953-7F49DAF9-16F6-48C8-AD63-748376DF6608Q37272785-5271C65A-3090-461B-BAB7-03831CC61CCFQ37294190-E0590075-07CB-4798-99A6-807FE184CE52Q38695734-F7593F12-3790-48DE-B4E3-C34DC4BA76D7Q38728567-102015CD-25EE-46C4-A2A1-EE1B7E9FEF4AQ39519100-0B758399-2DB4-4545-9AF4-5879110D7EE4Q40431485-2F102883-6878-4040-AF58-C9ECF7C794A7Q41083568-664AA6F6-7576-413F-BB1B-69DDDBD45FA0Q41191101-529BF470-57D4-400B-802E-CED471D9521BQ42371618-7433CF50-5E6C-44F9-82BD-CAC91630195EQ44440589-7F77E8B8-170E-4B43-8198-B024A37F3041Q46006826-E139C44B-29E7-4ECD-AACD-759FC8A984FEQ47985167-C657F3FB-D71A-4A70-8839-552F321F4534Q52331264-2A7E073D-D545-42A1-8166-D3869A414A48Q53272010-10D41B77-C73B-4F78-A98A-56ACEFF32786Q55514848-96FA9AFC-F276-43A5-8C53-664B13AA4C6DQ58551785-FF2479EB-A73E-45A3-B616-75EF6815707A
P2860
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The prognostic value of metfor ...... atic review and meta-analysis.
@en
type
label
The prognostic value of metfor ...... atic review and meta-analysis.
@en
prefLabel
The prognostic value of metfor ...... atic review and meta-analysis.
@en
P356
P1476
The prognostic value of metfor ...... atic review and meta-analysis.
@en
P304
P356
10.1111/DOM.12267
P577
2014-02-27T00:00:00Z